Ipca has been continuously evolving as an integrated pharmaceutical company over 65 years. Ipca has an annual turnover in excess of Rs.3,120 Crs with over 350 formulations and 80 APIs for various therapeutic segments. We are committed to Research & Development and expanding our R&D capabilities to build a strong future.
cGMP (current Good Manufacturing Practices) & Safety is a way of life. We are committed to further enhance cGMP and safety journey on continuous basis to deliver safe and quality products for mankind and to build a safe workplace for our employees.